...
首页> 外文期刊>Biomaterials >Collagen microencapsulation recapitulates mesenchymal condensation and potentiates chondrogenesis of human mesenchymal stem cells - A matrix-driven in vitro model of early skeletogenesis
【24h】

Collagen microencapsulation recapitulates mesenchymal condensation and potentiates chondrogenesis of human mesenchymal stem cells - A matrix-driven in vitro model of early skeletogenesis

机译:胶原蛋白微胶囊综合率促成了人间充质干细胞的间充质缩合和增强性软骨发生 - 早期骨骼发生的基质驱动的体外模型

获取原文
获取原文并翻译 | 示例

摘要

Mesenchymal condensation is a critical transitional stage that precedes cartilage or bone formation. A microencapsulation technique was previously established to entrap mesenchymal stem cells (MSC) in nanofibrous collagen meshwork. We hypothesize that collagen microencapsulation of MSCs mimics the mesenchymal cell condensation process. Specifically, human MSCs at different concentrations were microencapsulated in collagen for different time points before evaluation for early skeletogenesis markers. A transient upregulation of mesenchymal condensation markers including peanut agglutinin, fibronectin, integrins alpha 5 and alpha v, an enhanced nuclear localization of SOX9 and binding interactions with COL2A1, and other changes in chondrogenic, hypertropic and osteogenic marker were demonstrated. Collagen microencapsulation upregulated both the chondrogenic and the osteogenic transcription factors and the encapsulated hMSCs hold the potential to differentiate towards both chondrogenic and osteogenic lineages. We also hypothesize that collagen microencapsulation potentiates MSC chondrogenesis. Particularly, chondrogenic differentiation of hMSCs were induced at different time post-encapsulation before evaluation for chondrogenesis outcomes. Sustained SOX9, ACAN and COL2A1 expression were noted and the timing to induce supplement chondro-inductive factors matters. This study reports an extracellular matrix-based in vitro model of mesenchymal condensation, an early stage in skeletogenesis, contributing to rationalizing development-inspired tissue engineering.
机译:间充质凝结是软骨或骨形成之前的关键过渡阶段。先前建立了一种微胶囊化技术,以纳入纳米纤维胶原蛋白的间充质干细胞(MSC)。我们假设MSCs的胶原微胶囊化模仿间充质细胞缩合过程。具体而言,在评估早期骨膜发生标记的情况下,在胶原蛋白中以不同浓度的人体MSC微胶囊化。间充质缩合标记物的瞬态上调包括花生凝集素,纤连蛋白,整联蛋白α5和αv,增强SOX9的核定位和与COL2A1的结合相互作用以及软骨,高特许术和成骨标志物的其他变化。胶原蛋白微胶囊化上调软骨和成骨转录因子和包封的HMSCs均具有区分朝向软骨内和骨质发生谱系的可能性。我们还假设胶原蛋白微胶囊稳定性增强体MSC软骨发生。特别地,在对软骨发生结果的评估之前在封装前封装后的不同时间诱导HMSCs的软骨性分化。持续的SOX9,ACAN和COL2A1表达并注意到诱导补充软骨感应因素的时间。本研究报告了一种基于细胞外基质的间充质缩合的体外模型,骨骼发生的早期阶段,有助于合理化发展启发的组织工程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号